These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23076599)

  • 1. Macrophages as independent prognostic factors in small T1 breast cancers.
    Carrio R; Koru-Sengul T; Miao F; Glück S; Lopez O; Selman Y; Alvarez C; Milikowski C; Gomez C; Jorda M; Nadji M; Torroella-Kouri M
    Oncol Rep; 2013 Jan; 29(1):141-8. PubMed ID: 23076599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.
    Koru-Sengul T; Santander AM; Miao F; Sanchez LG; Jorda M; Glück S; Ince TA; Nadji M; Chen Z; Penichet ML; Cleary MP; Torroella-Kouri M
    Breast Cancer Res Treat; 2016 Jul; 158(1):113-126. PubMed ID: 27283835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
    Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
    J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea.
    Lee JS; Oh M; ;
    Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
    Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
    Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancers are increased in black women regardless of age or body mass index.
    Stead LA; Lash TL; Sobieraj JE; Chi DD; Westrup JL; Charlot M; Blanchard RA; Lee JC; King TC; Rosenberg CL
    Breast Cancer Res; 2009; 11(2):R18. PubMed ID: 19320967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women.
    Boone SD; Baumgartner KB; Joste NE; Pinkston CM; Yang D; Baumgartner RN
    Cancer Causes Control; 2014 Mar; 25(3):273-82. PubMed ID: 24337810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-infiltrating macrophages and clinical outcome in breast cancer.
    Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
    J Clin Pathol; 2012 Feb; 65(2):159-63. PubMed ID: 22049225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
    Wu Y; Khan H; Chillar R; Vadgama JV
    Int J Oncol; 1999 Jun; 14(6):1021-37. PubMed ID: 10339653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe.
    Deloumeaux J; Gaumond S; Bhakkan B; Manip M'Ebobisse N; Lafrance W; Lancelot P; Vacque D; Negesse Y; Diedhiou A; Kadhel P
    Cancer Epidemiol; 2017 Apr; 47():42-47. PubMed ID: 28119121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
    Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
    J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.
    Mukhtar RA; Moore AP; Tandon VJ; Nseyo O; Twomey P; Adisa CA; Eleweke N; Au A; Baehner FL; Moore DH; McGrath MS; Olopade OI; Gray JW; Campbell MJ; Esserman LJ
    Ann Surg Oncol; 2012 Nov; 19(12):3979-86. PubMed ID: 22622474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
    Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW
    Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.